Mauricio Merino Email Address

Chief Financial Officer, Senior Vice President of Corporate Development

G1 Therapeutics is a clinical-stage company developing small-molecule therapies to address significant unmet needs in oncology. The company is leveraging its proprietary kinase drug discovery platform to advance a pipeline of first-in-class compounds and best-in-class drug candidates.

Senior executive with a history of cross-functional experience in the life sciences industry including CFO of a public biotechnology company, member of the board of directors of more than a dozen public and private life-sciences companies (chairman of multiple audit committees and corporate governance committees), institutional life sciences venture capital and public-equity investing. Management style built on teamwork and collaboration. Skill set includes excellent communication and analytical skills as well as: corporate and financial strategy, financial planning and analysis, operational management, mergers and acquisitions, financial modeling, investor relations, valuation analysis, capital markets